SEC Comment Letter 0000000000-26-003267 to Nkarta, Inc. (NKTX)
Nkarta, Inc.
Date: March 31, 2026 · CIK: 0001787400 · Accession: 0000000000-26-003267
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294611
Letter
Re: Nkarta, Inc. Registration Statement on Form S-3 Filed March 25, 2026 File No. 333-294611 Dear Paul Hasting:
March 31, 2026
Paul Hasting Chief Executive Officer Nkarta, Inc. 1150 Veterans Boulevard South San Francisco, CA 94080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Brandon N. Wachs
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 31, 2026 Paul Hasting Chief Executive Officer Nkarta, Inc. 1150 Veterans Boulevard South San Francisco, CA 94080 Re: Nkarta, Inc. Registration Statement on Form S-3 Filed March 25, 2026 File No. 333-294611 Dear Paul Hasting: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brandon N. Wachs </TEXT> </DOCUMENT>